Figure 2.

Multivariable analyses of associations between baseline variables and the occurrence of MACE during tofacitinib treatment. For all continuous variables, unit = 1 unless specified; in unit = x, “x” is the change in the continuous variable corresponding to which the change in hazards is observed. Only variables with significant associations with occurrence of MACE are shown; this analysis also included baseline body mass index and time‐varying tofacitinib dosage (both not significant). See Figure 1 for definitions.